Once regarded as breakthrough drugs in the treatment of a wide range of psychiatric illnesses and addictive conditions, psychedelics were the subject of a major moral panic in the sixties because of their counter cultural associations. Research and treatment centres were shut down and the drugs relegated to Class A illegal substances. The last ten years have seen renewed and growing interest and research into the therapeutic benefits of psychedelics.

Dr Roberta Murphy is an Irish psychiatrist working in the Department of Brain Sciences at Imperial College London.  In conversation with Nuala O’Connor she talks about her work in Imperial’s Centre for Psychedelic Research and ‘PSILODEP 2’, the clinical trial set up to test the potential of psilocybin (magic mushrooms) in the treatment of depression.

Dr Roberta Murphy | Imperial Centre for Psychedelic Research 

In conversation with Nuala O’Connor | Ireland’s Edge

Hosted on Acast. See acast.com/privacy for more information.